> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Hikma Recalls Acetaminophen Lot Over Mix-up
- URL: https://www.fdaweb.com/hikma-recalls-acetaminophen-lot-over-mix-up/
- Published: 2024-07-23T12:00:00.000Z
- Updated: 2026-09-14T14:36:15.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5157405

Hikma Pharmaceuticals is extending a Class 1 recall of one lot of acetaminophen injection, 1,000mg/100mL due to the potential presence of a bag labeled dexmedetomidine HCl injection (400mcg/100mL) inside the overwrap that is labeled acetaminophen injection. If providers do not identify the drug inside the acetaminophen overwrap as dexmedetomidine and administer the drug to a patient, multiple potential adverse events could result including sedation, bradypnea, bradycardia, hypertension, and hypotension, a [recall notice](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hikma-pharmaceuticals-usa-inc-extends-voluntary-nationwide-recall-one-lot-acetaminophen-injection?ref=fdaweb.com) says. To date, Hikma has received one report of an adverse event.